𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Field trial of the efficacy of a simplified and standard metrifonate treatments ofSchistosoma haematobium

✍ Scribed by Y. Aden Abdi; L. L. Gustafsson

Publisher
Springer
Year
1989
Tongue
English
Weight
540 KB
Volume
37
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double blind, randomized clinical tria
A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of ‘vascular depression’
✍ Fernando E. Taragano; Ricardo Allegri; Augusto Vicario; Pablo Bagnatti; Constant 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## Background ‘Vascular depression’ may be caused by cerebrovascular disease. Calcium channel blockers, which are putative treatments for cerebrovascular disease, might be expected to improve depression reduction and to prevent recurrence of depression in this patient population. This

Efficacy and safety of incobotulinumtoxi
Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm—A randomized trial
✍ Joseph Jankovic; Cynthia Comella; Angelika Hanschmann; Susanne Grafe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract IncobotulinumtoxinA (NT 201, Xeomin) is a highly purified botulinum neurotoxin type A formulation, free from complexing proteins. A randomized, placebo‐controlled, double‐blind trial of efficacy and safety compared incobotulinumtoxinA (up to 50 U per eye) to placebo administered in a si

A randomized clinical trial to compare t
A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children
✍ S.K. Roy; A. Islam; R. Ali; K.E. Islam; R.A. Khan; S.H. Ara; N.M. Saifuddin; G.J 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 379 KB

To compare the clinical outcome of treatment of cholera in children with ampicillin, erythromycin or tetracycline, a double-'blind' randomized four-cell trial was carried out in Bangladesh. Ampicillin was chosen as additional therapy for acute respiratory tract infection, present in many subjects wi